Sanofi Vaccine Covid Us. Sanofi and gsk signed a $2.1bn (£1.6bn) deal with washington during the summer to supply it with more than 100 million doses of the same vaccine, which they hope to present for regulatory. The trial will involve 440 healthy adults, with the drugmakers expecting preliminary results.
The company is expected to release the results from the phase i/ii clinical trials this month. The sanofi vaccine, one of many in development, will be available for distribution in june 2021. Regulatory approval in the first half of 2021.
If the data are positive, the companies can request u.s.
The sanofi vaccine, one of many in development, will be available for distribution in june 2021. Sanofi is pursuing two vaccine candidates. It is also developing a vaccine with u.s. The trial will enroll 440 healthy adults in the us to evaluate the vaccine’s safety, tolerability and immune response.